Free Trial

Charles Schwab Investment Management Inc. Sells 55,452 Shares of Varex Imaging Co. (NASDAQ:VREX)

Varex Imaging logo with Medical background
Remove Ads

Charles Schwab Investment Management Inc. cut its position in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 395,006 shares of the company's stock after selling 55,452 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.96% of Varex Imaging worth $5,763,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Quest Partners LLC bought a new stake in Varex Imaging in the third quarter valued at $41,000. US Bancorp DE raised its holdings in shares of Varex Imaging by 149.8% during the fourth quarter. US Bancorp DE now owns 7,386 shares of the company's stock valued at $108,000 after buying an additional 4,429 shares during the last quarter. New York State Common Retirement Fund boosted its position in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after buying an additional 3,600 shares during the period. Intech Investment Management LLC grew its holdings in Varex Imaging by 13.7% in the 3rd quarter. Intech Investment Management LLC now owns 16,267 shares of the company's stock worth $194,000 after buying an additional 1,959 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Varex Imaging in the 3rd quarter valued at approximately $204,000.

Analysts Set New Price Targets

VREX has been the subject of several recent analyst reports. Oppenheimer decreased their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a report on Friday, February 7th. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a report on Friday, February 7th. Finally, B. Riley reaffirmed a "buy" rating and issued a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th.

Remove Ads

View Our Latest Research Report on VREX

Insider Buying and Selling at Varex Imaging

In related news, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now directly owns 4,002 shares in the company, valued at $51,265.62. This trade represents a 50.03 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 4.30% of the company's stock.

Varex Imaging Stock Performance

Shares of NASDAQ:VREX traded down $0.50 during midday trading on Friday, hitting $11.52. The company's stock had a trading volume of 467,536 shares, compared to its average volume of 542,019. Varex Imaging Co. has a fifty-two week low of $10.19 and a fifty-two week high of $18.30. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. The stock has a market capitalization of $474.62 million, a price-to-earnings ratio of -9.85 and a beta of 0.56. The stock's 50 day simple moving average is $13.17 and its 200 day simple moving average is $13.42.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, research analysts anticipate that Varex Imaging Co. will post 0.53 earnings per share for the current year.

About Varex Imaging

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Articles

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads